An Exploratory Randomized Trial of SCO-792, an Enteropeptidase Inhibitor, in Patients With Type 2 Diabetes and Albuminuria

INTRODUCTION: Elevated plasma amino acid levels overload kidney function by increasing glomerular filtration rate (GFR). Inhibiting gut amino acid intake may have therapeutic benefits for patients with kidney dysfunction. For a prospective phase 2a trial, we carried out an exploratory evaluation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kagawa, Tomoya, Sugama, Jun, Nishizaki, Harunobu, Moritoh, Yusuke, Watanabe, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831944/
https://www.ncbi.nlm.nih.gov/pubmed/36644351
http://dx.doi.org/10.1016/j.ekir.2022.10.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831944/
https://www.ncbi.nlm.nih.gov/pubmed/36644351
http://dx.doi.org/10.1016/j.ekir.2022.10.006

Ejemplares similares